Timber Pharmaceuticals Stock

Timber Pharmaceuticals Dividend 2024

Timber Pharmaceuticals Dividend

0 USD

Timber Pharmaceuticals Dividend yield

Ticker

TMBR

ISIN

US8870801094

WKN

A2P4ZX

How much dividend does Timber Pharmaceuticals 2024 pay?

According to the latest status from October 2024, Timber Pharmaceuticals paid a total of 0 USD per share in dividends within the last 12 months. With the current Timber Pharmaceuticals price of 0 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Timber Pharmaceuticals Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Timber Pharmaceuticals Dividend Safe?

Timber Pharmaceuticals has been increasing the dividend for 0 years.

Over the past 10 years, Timber Pharmaceuticals has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Timber Pharmaceuticals's Dividend Distributions

Timber Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Timber Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Timber Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Timber Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Timber Pharmaceuticals Aktienanalyse

What does Timber Pharmaceuticals do?

Timber Pharmaceuticals Inc. is a dynamic pharmaceutical company based in Woodcliff Lake, New Jersey, USA. The company was founded in 2019 and specializes in the development and marketing of novel therapies for the treatment of skin disorders and rare dermatological conditions. Timber Pharmaceuticals' business model is focused on finding innovative medical solutions and implementing them in research, development, and marketing. The company collaborates closely with renowned medical institutions and experts, aiming to provide high-quality and reliable treatment options for both patients and healthcare providers. Timber Pharmaceuticals is divided into two main divisions: dermatology and rare diseases. In the field of dermatology, the company develops a wide range of treatments, including topical applications and systemic therapies, with the goal of improving patients' quality of life by alleviating their symptoms. The rare diseases division focuses on the development of highly specialized medications for the treatment of rare, genetically inherited skin conditions. These treatments aim to provide targeted therapy for patients with such conditions, tailored to their specific diseases. Some important products of Timber Pharmaceuticals include TMB-001, TMB-002, TMB-003, and TMB-310. TMB-001 is a topical gel developed to improve wound healing in patients with chronic wounds or ulcerating lesions. TMB-002 is a systemic therapy for the treatment of patients with atopic dermatitis, an inflammatory skin condition. TMB-003 is a topical medication for the treatment of molluscum contagiosum, a viral skin disease. TMB-310 is a novel medication for the treatment of Congenitalichthyosis, a rare genetic skin disorder. Timber Pharmaceuticals has experienced rapid growth in a short period of time and has become a significant player in the American pharmaceutical market. The company has achieved an impressive list of milestones, including partnerships with other pharmaceutical companies and medical institutions, as well as obtaining approvals for clinical trials. Overall, Timber Pharmaceuticals has an ambitious strategy focused on the development of novel treatments for patients with skin problems. The company has established itself as a reliable partner for medical institutions and other pharmaceutical companies and now aims to revolutionize the treatment of rare skin diseases. With innovative solutions and strong growth, Timber Pharmaceuticals is on track to become one of the leading pharmaceutical companies in the global market. The answer to the output question is: Timber Pharmaceuticals specializes in the development and marketing of novel therapies for skin disorders and rare dermatological conditions. Timber Pharmaceuticals is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Timber Pharmaceuticals stock

How much dividend does Timber Pharmaceuticals pay?

Over the past 12 months, Timber Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Timber Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Timber Pharmaceuticals?

The current dividend yield of Timber Pharmaceuticals is .

When does Timber Pharmaceuticals pay dividends?

Timber Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Timber Pharmaceuticals?

Timber Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Timber Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Timber Pharmaceuticals located?

Timber Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Timber Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Timber Pharmaceuticals from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Timber Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Timber Pharmaceuticals in the year 2023?

In the year 2023, Timber Pharmaceuticals distributed 0 USD as dividends.

In which currency does Timber Pharmaceuticals pay out the dividend?

The dividends of Timber Pharmaceuticals are distributed in USD.

Andere Kennzahlen von Timber Pharmaceuticals

Our stock analysis for Timber Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Timber Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.